ANALYSIS OF PNEUMOCOCCAL VACCINATION EFFICACY AND SAFETY IN CHILDREN WITH VARIOUS DISABILITIES OF HEALTH

ANALYSIS OF PNEUMOCOCCAL VACCINATION EFFICACY AND SAFETY IN CHILDREN WITH VARIOUS DISABILITIES OF HEALTH

The results of vaccination tolerability assessment against pneumococcal infection in children with various disabilities of health as well as the results of the follow-up of the vaccinated children are cited. The work was carried out at the Vaccination Department of the Scientific Centre for Children...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. G. Gaivoronskaya, L. S. Namazova-Baranova, M. G. Galitskaya, T. A. Grechukha, N. E. Tkachenko, M. I. Ivardava
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2012-04-01
Series:	Педиатрическая фармакология
Subjects:	pneumococcal disease prevention vaccination children with the health disabilities efficiency safety
Online Access:	https://www.pedpharma.ru/jour/article/view/343
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

EXPERIENCE OF APPLICATION AND SAFETY ASSESSMENT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN UNDER-5 CHILDREN
by: M. V. Fedoseenko, et al.
Published: (2014-09-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma
by: Tatiana A. Kaliuzhnaia, et al.
Published: (2020-11-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

A Decade of Experience in the use of 13-Valent Conjugated Polysaccharide Pneumococcal Vaccine in Russian Federation
by: N. I. Briko, et al.
Published: (2023-09-01)

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024
by: King-Pui Florence Chan, et al.
Published: (2025-05-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

The New Era of Pneumococcal Vaccination in Adults: What Is Next?
by: Lale Ozisik
Published: (2025-05-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

EXPERIENCE OF IMPLEMENTATION OF THE COHORT PNEUMOCOCCAL VACCINATION PROGRAM FOR INFANTS IN ST. PETERSBURG
by: S. M. Kharit, et al.
Published: (2014-05-01)

Immunogenicity, Safety, and Clinical Eﬀectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Spondyloarthritis (Preliminary Data)
by: M. M. Baranova, et al.
Published: (2022-04-01)

What do Patients Know About Pneumococcal Vaccine?
by: Fatma Çiftci, et al.
Published: (2017-08-01)

Pneumococcal Vaccine for Infants and Toddlers
by: T. Mitchell
Published: (2006-08-01)

Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States
by: Zinan Yi, et al.
Published: (2024-11-01)

Modern Approaches to Vaccinal Prevention of a Pneumococcal Infection in Adults Patients with Diabetes Mellitus (Literature Review)
by: J. A. Paramonova, et al.
Published: (2018-04-01)

Global distribution and characteristics of pneumococcal serotypes in adults
by: Haruka Maeda, et al.
Published: (2025-12-01)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
by: N. L. Chernaya, et al.
Published: (2012-02-01)

Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination
by: I. N. Protasova, et al.
Published: (2021-12-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

Pneumococcal Vaccination of Patients with Juvenile Idiopathic Arthritis: Review of International Experience
by: Margarita A. Soloshenko, et al.
Published: (2017-04-01)

Pneumococcal Vaccination Coverage Among Adults at Risk in the Russian Federation
by: V. A. Korshunov, et al.
Published: (2025-01-01)

IAPSM’s Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India
by: Chythra R. Rao, et al.
Published: (2024-12-01)

Analysis of the Compliance of the Vaccination Schedule against Pneumococcal Infection in Young Children
by: I. V. Feldblium, et al.
Published: (2018-10-01)

The Relevance of Vaccination against Pneumococcal Disease to the Child Population of Krasnoyarsk
by: G. P. Martynova, et al.
Published: (2015-04-01)

Vaccination against pneumococcal infection in patients with chronic kidney disease
by: A. A. Tarasova, et al.
Published: (2020-09-01)

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01)

Vaccination in Aged Care in Australia: A Retrospective Study of Influenza, Herpes Zoster, and Pneumococcal Vaccination
by: Stephen Wiblin, et al.
Published: (2025-07-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population
by: Ann-Charlotte Fridh, et al.
Published: (2024-12-01)

State of pneumococcal vaccine immunity
by: Mustafa Akkoyunlu
Published: (2024-12-01)

PROPHYLACTIC EFFICACY OF VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN CHILDREN WITH CHRONIC ADENOTONSILLAR DISEASES
by: S. N. Beniova, et al.
Published: (2015-08-01)

Theoretical Background and Real Results: A Data Review on Vaccine Prevention of Pneumococcal Infection in the World
by: Leyla S. Namazova-Baranova, et al.
Published: (2018-02-01)

The Results of a Three-Year Pneumococcal Vaccination of Children in Russia
by: Nikolay I. Briko, et al.
Published: (2018-10-01)

Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection
by: M. V. Savkina, et al.
Published: (2021-12-01)